• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Local Data Minnesota

Local Data: Minnesota

There are approximately 24,300 people living with Hepatitis C in Minnesota.

Minnesota

Want to view more?

View Interactive Map

Jump to:

  • Prevalence
  • Mortality
  • Demographics
  • Age
  • Other Data Comparisons

Hepatitis C Prevalence

Estimated number of people living with Hepatitis C, 2013-2016 24,300

Estimated rate of people living with Hepatitis C per 100,000 population, 2013-2016 580

Estimated percent of people living with Hepatitis C, by Sex, 2013-2016

71.1% 28.9%
  • Male
  • Female

Estimated percent of people living with Hepatitis C, by Race/Ethnicity, 2013-2016

28.4% 71.6%
  • Black
  • Non-Black

Estimated percent of people living with Hepatitis C, by Age, 2013-2016

2.6% 74.0% 23.4%
  • Less than 50
  • 50-74 (Baby Boomer)
  • 75 and above

Estimated rate of people living with Hepatitis C per 100,000 population, by Geography, 2013-2016

1000 800 600 400 200 0 580.0 State 747.0 Region 926.5 United States

Hepatitis C Mortality

Number of deaths related to Hepatitis C, 2017 235

Rate of deaths related to Hepatitis C per 100,000 population, 2017 4

Percent of deaths of people related to Hepatitis C, by Sex, 2017

71.1% 28.9%
  • Male
  • Female

Percent of deaths of people related to Hepatitis C, by Race/Ethnicity, 2017

11.5% 18.3% 67.2% 3.0%
  • American Indian or Alaska Native, Asian or Pacific Islander, or Hispanic/Latinx
  • Black
  • White
  • Data suppressed or not available

Percent of deaths of people related to Hepatitis C, by Age, 2017

88.1% 11.9%
  • 50-74 (Baby Boomer)
  • Data suppressed or not available

Number of deaths related to Hepatitis C, 2013-2017

2013 2014 2015 2016 2017 200 250 300 229 245 234 240 235

Rate of deaths related to Hepatitis C per 100,000 population, by Geography, 2017

10 8 6 4 2 0 4.0 State 3.6 Region 5.3 United States

Demographics, 2017

Total Population 5,576,606

State Population By Age

  • Less than 50 (64.6%)
  • 50-74 (Baby Boomer) (28.9%)
  • 75 and above (6.6%)

Hepatitis C, by Age

Estimated Percent of People Living with Hepatitis C, by Age, 2013-2016

Percent of Deaths Related to Hepatitis C, by Age, 2017

  • Less than 50
  • 50-74 (Baby Boomer)
  • 75 and above
  • Data suppressed or not available

Opioid Indicators

Opioid Prescription Rate, 2020 30.2

Pain Reliever Misuse Percent, 2019-2020 2.9

Social Determinants of Health, 2018

  • State
  • Region
  • United States
92.9% 90.2% 87.5%

Percent of Population with a High School Education, 2018

0.450 0.465 0.481

Income Inequality (Gini Coefficient), 2018

9.9% 13.2% 14.0%

Percent of Population Living in Poverty, 2018

$65,583 $55,712 $59,039

Median Household Income, 2018

4.8% 7.4% 8.6%

Percent of Population Lacking Health Insurance, 2018

Viral Hepatitis Treatment Restrictions

Prior Authorization

State Medicaid programs may require patients to receive prior authorization in order to receive treatment for Hepatitis C.

PA Required PA Removed

Fibrosis Level Treatment Restrictions

State Medicaid programs may require a patient to reach a certain stage of fibrosis (liver scarring) before being able to access treatment for Hepatitis C.

F3 F2 F1 No Restrictions

Substance Use Treatment Restrictions

State Medicaid programs may require a period of abstinence from drugs or alcohol prior to or during treatment or require providers to counsel their patients regarding drug or alcohol use before being able to access treatment for Hepatitis C.

6 Months 3 Months Abstinence Screening and Counseling No Restrictions

Prescriber Treatment Restrictions

State Medicaid programs may require a prescription for Hepatitis C treatment to be issued by or in consultation with a specialist.

Specialist By or in Consultation No Restrictions

Retreatment Restrictions

State Medicaid programs may require more severe restrictions for patients seeking retreatment for Hepatitis C.

Retreatment Restrictions No Restrictions

Statuses of state Medicaid restrictions are as of February 2023. Source: CHLPI and NVHR.

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.